Ipsen Financial Statements From 2010 to 2024
| I7G Stock | EUR 107.30 0.20 0.19% |
Check Ipsen SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ipsen SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ipsen financial statements analysis is a perfect complement when working with Ipsen SA Valuation or Volatility modules.
Ipsen |
Ipsen SA Company Profit Margin Analysis
Ipsen SA's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Ipsen SA Profit Margin | 0.21 % |
Most of Ipsen SA's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ipsen SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Ipsen SA has a Profit Margin of 0.2055%. This is 101.83% lower than that of the Healthcare sector and 103.47% lower than that of the Drug Manufacturers - Specialty & Generic industry. The profit margin for all Germany stocks is 116.18% lower than that of the firm.
Ipsen SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ipsen SA's current stock value. Our valuation model uses many indicators to compare Ipsen SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ipsen SA competition to find correlations between indicators driving Ipsen SA's intrinsic value. More Info.Ipsen SA is rated fourth overall in return on equity category among its peers. It also is rated fourth overall in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ipsen SA is roughly 1.89 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ipsen SA's earnings, one of the primary drivers of an investment's value.About Ipsen SA Financial Statements
Ipsen SA stakeholders use historical fundamental indicators, such as Ipsen SA's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ipsen SA investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ipsen SA's assets and liabilities are reflected in the revenues and expenses on Ipsen SA's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ipsen SA. Please read more on our technical analysis and fundamental analysis pages.
Ipsen S.A. operates as a biopharmaceutical company worldwide. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. IPSEN S operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5700 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Ipsen Stock
Ipsen SA financial ratios help investors to determine whether Ipsen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ipsen with respect to the benefits of owning Ipsen SA security.